FOXA1 and breast carcinoma: A 2023 study by Liu et al., identifies FOXA1, a transcription factor involved in epigenetic reprogramming crucial for breast cancer progression, implements its oncogenic function via O-linked β-N-acetylglucosamine modification (O-GlcNAcylation) of FOXA1.